ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $211 | -33.0% | 7,860 | -10.9% | 0.15% | -30.3% |
| Q2 2023 | $315 | +38.2% | 8,821 | -1.8% | 0.22% | +27.0% |
| Q1 2023 | $228 | -37.4% | 8,981 | -0.1% | 0.17% | -39.8% |
| Q4 2022 | $364 | -99.9% | 8,986 | -4.7% | 0.29% | +6.2% |
| Q3 2022 | $312,000 | -6.0% | 9,428 | 0.0% | 0.27% | -3.5% |
| Q2 2022 | $332,000 | -23.9% | 9,428 | -0.6% | 0.28% | -6.0% |
| Q1 2022 | $436,000 | -30.9% | 9,488 | -0.3% | 0.30% | -28.7% |
| Q4 2021 | $631,000 | – | 9,518 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |